Trials / Completed
CompletedNCT04494464
Treatment Rates and Compliance to Treatment in Patients With Familial Hypercholesterolemia
Awareness, Treatment Rates and Compliance to Treatment in Patients With Serum LDL Cholesterol Higher Than 250 mg/dL, and Possible, Probable or Definite Familial Hypercholesterolemia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 367 (actual)
- Sponsor
- Ankara Yildirim Beyazıt University · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- —
Summary
Familial hypercholesterolemia is a genetic disease characterized by increased levels of low density lipoprotein cholesterol (LDL-C). It is underdiagnosed and undertreated despite relatively high prevalence and significant association with increased mortality.
Detailed description
Patients older than 18 years old and have a serum low density LDL-C≥250 mg/dL were identified from the hospital database. A questionnaire was completed via phone. Patients were classified as definite, probable and possible familial hypercholesterolemia according to Dutch Lipid Clinical Network Criteria
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2017-05-01
- Completion
- 2017-05-01
- First posted
- 2020-07-31
- Last updated
- 2020-07-31
Source: ClinicalTrials.gov record NCT04494464. Inclusion in this directory is not an endorsement.